Skip to main content

Table 2 Symptomatology and clinical evaluation in patients based on the outcome

From: Predictors of mortality of hospitalized COVID-19 pneumonia patients in university hospital

 

Survivors group (n = 147)

Non-survivor group (n = 104)

p-value

Duration of symptoms

8.06 ± 5.37

7.34 ± 3.96

0.24

Anosmia

40 (27.2%)

23 (22.1%)

0.22

Diarrhea

24 (16.3%)

10 (9.6%)

0.08

Fever

125 (85%)

92 (88.5%)

0.27

Dyspnea

121 (82.3%)

99 (95.2%)

 < 0.001

Cough

128 (87.1%)

90 (86.5%)

0.52

Dyspnea scale

3.45 ± 0.77

3.94 ± 0.29

 < 0.001

CURB-65

1.37 ± 1.02

2.45 ± 1.07

 < 0.001

PSI

82.96 ± 32.68

111.27 ± 26.70

 < 0.001

Temperature (°C)

37.53 ± 0.79

37.67 ± 0.64

0.15

Heart rate (b/m)

93.65 ± 15.35

100.53 ± 20.57

 < 0.001

SBP (mmHg)

123.87 ± 21.21

115.48 ± 25.46

 < 0.001

DBP (mmHg)

77.89 ± 12.34

71.44 ± 16.97

 < 0.001

RR (cycle/m)

28.93 ± 6.58

34.17 ± 7.75

 < 0.001

Pulse oximetry saturation

82.83 ± 13.50

73.63 ± 15.71

 < 0.001

  1. Data expressed as mean (SD), frequency (percentage). p-value was significant if < 0.05
  2. PSI pneumonia severity index, RR respiratory rate, DBP diastolic blood pressure, SBP systolic blood pressure